International Clinical Trial: Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07201558) titled 'Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants' on Sept. 30.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: AstraZeneca

Condition: Rheumatoid Arthritis Systemic Lupus Erythematosus

Intervention: Biological: Surovatamig

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: November 28, 2025

Target Sample Size: 48

To know more, visit https://clinicaltrials.gov/study/NCT07201558

Published by HT Digital Content Ser...